90 related articles for article (PubMed ID: 16107887)
41. Re: Rust et al. TIMP-1 expression in anaplastic large cell lymphoma is usually restricted to macrophages and only seldom observed in tumour cells. J Pathol 2005;206:445-450.
Lai R; Leventaki V; Rassidakis GZ
J Pathol; 2005 Nov; 207(3):372-3; author reply 374-5. PubMed ID: 16161018
[No Abstract] [Full Text] [Related]
42. Plasmacytic ALK-positive large B-cell lymphoma: a potential mimic of extramedullary plasmacytoma.
Hashimoto T; Fujimoto M; Nishikori M; Takeuchi K; Kimura M; Nakajima N; Miyagawa-Hayashino A; Takaori-Kondo A; Haga H
Pathol Int; 2014 Jun; 64(6):292-4. PubMed ID: 24965113
[No Abstract] [Full Text] [Related]
43. 'Lymphochips' and cancer profiles.
Bustin SA
Mol Med Today; 2000 Jun; 6(6):218. PubMed ID: 10939839
[No Abstract] [Full Text] [Related]
44. Innovative therapies based on molecular orientation in patients with relapse and refractory diffuse large B-cell lymphoma: Results of LNH-EP1 study.
Sarkozy C; Michot JM; Quivoron C; Camara-Clayette V; Danu A; Lazarovici J; El-Dakdouki Y; Saleh K; Ghez D; Rossignol J; Baldini C; Arfi-Rouche J; Romano-Martin P; Tselikas L; Varga A; Gazzah A; Hollebecque A; Lacroix L; Bahleda R; Lecourt H; Vergé V; Rahali W; Cotteret S; Soria JC; Dartigues P; Massard C; Ribrag V
Am J Hematol; 2021 Oct; 96(10):E376-E379. PubMed ID: 34165816
[No Abstract] [Full Text] [Related]
45. Hematology morphology forum.
Kansu E; Uner A; McArthur JR
Hematology; 2004 Jun; 9(3):243-4. PubMed ID: 15204107
[No Abstract] [Full Text] [Related]
46. Multiple recurrent extra-medullary relapses of high-grade diffuse large B-cell lymphoma presenting in acute leukemic phase.
Jain P; Sargent RL; Konoplev SN; Benjamini O; Kantarjian H; Kadia T
Am J Hematol; 2013 May; 88(5):433-4. PubMed ID: 23460270
[No Abstract] [Full Text] [Related]
47. Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series.
Wise JF; Nakken S; Steen CB; Vodák D; Trøen G; Johannessen B; Lingjærde OC; Hilden V; Blaker YN; Bai B; Aasheim LB; Pasanen A; Lorenz S; Sveen A; Lothe RA; Myklebost O; Leppä S; Meza-Zepeda LA; Beiske K; Lawrence MS; Hovig E; Myklebust JH; Smeland EB; Holte H
Blood Adv; 2020 May; 4(9):1859-1866. PubMed ID: 32374878
[TBL] [Abstract][Full Text] [Related]
48. [Not Available].
Hjorth MK; Kamstrup MR
Ugeskr Laeger; 2024 Feb; 186(9):. PubMed ID: 38445325
[No Abstract] [Full Text] [Related]
49. Ovarian ALK+ diffuse large B-cell lymphoma: a case report and a review of the literature.
Sellami-Dhouib R; Nasfi A; Mejri NT; Doghri R; Charfi L; Sassi S; Abbes I; Mrad K; Ben Hamida N; Driss MP; Ben Romdhane K
Int J Gynecol Pathol; 2013 Sep; 32(5):471-5. PubMed ID: 23896707
[TBL] [Abstract][Full Text] [Related]
50. ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements.
Valera A; Colomo L; Martínez A; de Jong D; Balagué O; Matheu G; Martínez M; Taddesse-Heath L; Jaffe ES; Bacchi CE; Campo E
Mod Pathol; 2013 Oct; 26(10):1329-37. PubMed ID: 23599149
[TBL] [Abstract][Full Text] [Related]
51. STAT3 pathway is activated in ALK-positive large B-cell lymphoma carrying SQSTM1-ALK rearrangement and provides a possible therapeutic target.
d'Amore ES; Visco C; Menin A; Famengo B; Bonvini P; Lazzari E
Am J Surg Pathol; 2013 May; 37(5):780-6. PubMed ID: 23588372
[TBL] [Abstract][Full Text] [Related]
52. A case of anaplastic lymphoma kinase-positive large B-cell lymphoma: aspiration cytology findings.
Nakatsuka S; Oku K; Nagano T; Kimura H; Hanamoto A; Ito M; Hashimoto K
Diagn Cytopathol; 2014 Jan; 42(1):69-72. PubMed ID: 23457005
[TBL] [Abstract][Full Text] [Related]
53. Anaplastic lymphoma kinase-positive large B-cell lymphoma: a case report with particular immunophenotypic features.
Llamas-Gutiérrez FJ; Deffis Court M; Ponciano Castellanos A; González de Cantú K; Aguilar-Guadarrama R; Aguilar León D; Montes Moreno S; Lome-Maldonado C
Hum Pathol; 2013 Jul; 44(7):1429-33. PubMed ID: 23352208
[TBL] [Abstract][Full Text] [Related]
54. ALK-positive large B-cell lymphoma presenting with jejunal intussusception.
Chen YP; Hung LY; Shan YS; Chang KC
Eur J Haematol; 2013 Mar; 90(3):261. PubMed ID: 23171433
[No Abstract] [Full Text] [Related]
55. ALK+ large B-cell lymphoma: a rare variant of aggressive large B-cell lymphoma mimicking carcinoma on cytology specimens.
Lin O; Koreishi A; Brandt SM; Arcila M; Teruya-Feldstein J
Diagn Cytopathol; 2013 May; 41(5):404-7. PubMed ID: 22351377
[TBL] [Abstract][Full Text] [Related]
56. ALK-positive diffuse large B-cell lymphoma with the t(2;17)(p23;q23).
Zhang D; Denley RC; Filippa DA; Teruya-Feldstein J
Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):172-7. PubMed ID: 19521280
[TBL] [Abstract][Full Text] [Related]
57. Diffuse large cell, B-cell type lymphoma with a novel translocation (2;22)(p23;q11.2).
Park JP; Curran MJ; Levy NB; Davis TH; Elliott JH; Mohandas TK
Cancer Genet Cytogenet; 1997 Jul; 96(2):118-22. PubMed ID: 9216718
[TBL] [Abstract][Full Text] [Related]
58. Anaplastic Lymphoma Kinase Positive Large B-Cell Lymphoma: Diagnostic Perils and Pitfalls, an Underrecognized Entity.
Chowdhury Z
Cureus; 2021 Aug; 13(8):e16882. PubMed ID: 34513457
[TBL] [Abstract][Full Text] [Related]
59. Diagnosis and treatment of pediatric anaplastic lymphoma kinase-positive large B-cell lymphoma: A case report.
Zhang M; Jin L; Duan YL; Yang J; Huang S; Jin M; Zhu GH; Gao C; Liu Y; Zhang N; Zhou CJ; Gao ZF; Zheng QL; Chen D; Zhang YH
World J Clin Cases; 2021 Jun; 9(17):4268-4278. PubMed ID: 34141790
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
